StemBioSys develops proprietary stem cell technologies for the regenerative medicine market.
StemBioSys has raised $72K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in September 2024.
StemBioSys's investors include Targeted Technology Fund.
StemBioSys is headquartered in San Antonio, United States.
StemBioSys develops proprietary stem cell technologies for the regenerative medicine market.
StemBioSys is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StemBioSys — Funding & Investors." VCBacked, September 4, 2024, https://www.vcbacked.co/company/stembiosys. Accessed September 30, 2026.
VCBacked. (2024). StemBioSys — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/stembiosys
{{cite web |title=StemBioSys — Funding & Investors |url=https://www.vcbacked.co/company/stembiosys |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated